Bihua Chen

Companies

• BlossomHill Therapeutics, Inc.Board member Aug 6, 2026 to now¹
• Helix Acquisition Corp. IIIChief executive officer Jan 22, 2026 to now²
• Helix Acquisition Corp. IIIChair Jan 22, 2026 to now²
• BridgeBio Oncology Therapeutics, Inc.Board member Aug 13, 2025 to now³
• Biomea Fusion, Inc.Board member Apr 15, 2021 to now⁴
• BridgeBio Oncology Therapeutics, Inc.Chief executive officer Feb 9, 2024 to Feb 10, 2025⁵
• BridgeBio Oncology Therapeutics, Inc.Chair Feb 9, 2024 to Feb 10, 2025⁵
• Erasca, Inc.Board member Jul 15, 2021 to Jun 26, 2023⁶
• Monte Rosa TherapeuticsBoard member Jun 23, 2021 to Jun 23, 2021⁷
• Verve Therapeutics, Inc.Board member Jun 16, 2021 to Jun 23, 2021⁸
• Rain Oncology Inc.Board member Apr 22, 2021 to Apr 29, 2021⁹
• Design Therapeutics, Inc.Board member Mar 25, 2021 to Mar 25, 2021¹⁰
• Prometheus Biosciences, Inc.Board member Mar 11, 2021 to Mar 18, 2021¹¹
• BioAtlaBoard member Dec 15, 2020 to Dec 22, 2020¹²
• Olema Pharmaceuticals, Inc.Board member Nov 18, 2020 to Nov 23, 2020¹³
• Atea Pharmaceuticals, Inc.Board member Oct 29, 2020 to Nov 5, 2020¹⁴
• MoonLake ImmunotherapeuticsChief executive officer Oct 19, 2020 to Oct 22, 2020¹⁵
• MoonLake ImmunotherapeuticsChair Oct 19, 2020 to Oct 22, 2020¹⁵
• Akouos, Inc.Board member Jun 25, 2020 to Jul 2, 2020¹⁶
• Avidity Biosciences, Inc.Board member Jun 11, 2020 to Jun 18, 2020¹⁷
• Turning Point Therapeutics, Inc.Board member Apr 25, 2019 to Aug 12, 2019¹⁸
• Axonics, Inc.Board member Oct 30, 2018 to Nov 2, 2018¹⁹
• Constellation Pharmaceuticals (United States)Board member Jul 18, 2018 to Jul 20, 2018²⁰
• Kezar Life Sciences, Inc.Board member Jun 20, 2018 to Jun 27, 2018²¹
• Kiniksa Pharmaceuticals International, plcBoard member May 23, 2018 to May 31, 2018²²
• Proteostasis Therapeutics (United States)Board member Nov 7, 2016 to Dec 18, 2017²³
• Apellis Pharmaceuticals, Inc.Board member Nov 8, 2017 to Nov 14, 2017²⁴
• Clearside Biomedical, Inc.Board member Jun 13, 2016 to Jun 13, 2016²⁵
• Cellectar Biosciences, Inc.Board member Sep 5, 2014 to Sep 5, 2014²⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• EErasca, Inc. ERAS10,813,246 shares²⁷$162.2M at $15.00Jun 26, 2023
• MIMoonLake Immunotherapeutics MLTX3,677,100 shares²⁸$35.7M at $9.72Jul 5, 2023
• HAHelix Acquisition Corp. III HLXC800,000 shares²⁹$8.3M at $10.36Jan 26, 2026
• BOBridgeBio Oncology Therapeutics, Inc. BBOT1,905,046 shares³⁰$5.3M at $2.81Jul 6, 2026
• BFBiomea Fusion, Inc. BMEA3,570,872 shares³¹$3.0M at $0.85Aug 1, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 1, 2026Other 130,865 shares of BridgeBio Oncology Therapeutics, Inc.³⁰
• Jul 1, 2026Other 1,704,862 shares of BridgeBio Oncology Therapeutics, Inc.³⁰
• Jul 1, 2026Other 2,692,459 shares of BridgeBio Oncology Therapeutics, Inc.³⁰
• Jul 1, 2026Other 4,528,186 shares of BridgeBio Oncology Therapeutics, Inc.³⁰
• Jan 26, 2026Bought 800,000 shares at $10.00 of Helix Acquisition Corp. III²⁹
• Jan 26, 2026Granted 497,500 shares at $10.00 of Helix Acquisition Corp. III²⁹
• Dec 11, 2025Sold 30,029 shares at $11.46 of Corbus Pharmaceuticals³²
• Aug 11, 2025Granted 284,571 shares of BridgeBio Oncology Therapeutics, Inc.³³
• Aug 11, 2025Granted 1,762,760 shares of BridgeBio Oncology Therapeutics, Inc.³³
• Aug 11, 2025Granted 1,905,046 shares of BridgeBio Oncology Therapeutics, Inc.³³
• Aug 11, 2025Granted 5,598,425 shares at $10.72 of BridgeBio Oncology Therapeutics, Inc.³³
• Aug 11, 2025Granted 639,110 shares at $10.72 of BridgeBio Oncology Therapeutics, Inc.³³
• Aug 11, 2025Granted 760,496 shares at $10.72 of BridgeBio Oncology Therapeutics, Inc.³³
• Aug 11, 2025Returned to company 152,940 shares of BridgeBio Oncology Therapeutics, Inc.³³
• Aug 11, 2025Exercised options 4,172,126 shares of BridgeBio Oncology Therapeutics, Inc.³³
• Feb 14, 2025Bought 187,500 shares at $16.00 of Aardvark Therapeutics, Inc.³⁴
• Feb 14, 2025Converted 800,189 shares of Aardvark Therapeutics, Inc.³⁴
• Sep 27, 2024Bought 450,000 shares at $18.00 of BioAge Labs, Inc.³⁵
• Sep 27, 2024Converted 1,179,529 shares of BioAge Labs, Inc.³⁵
• Mar 8, 2024Bought 8,862 shares at $45.96 of Corbus Pharmaceuticals³⁶
• Mar 8, 2024Bought 156,597 shares at $45.26 of Corbus Pharmaceuticals³⁶
• Mar 8, 2024Bought 61,668 shares at $44.62 of Corbus Pharmaceuticals³⁶
• Mar 8, 2024Bought 18,548 shares at $43.26 of Corbus Pharmaceuticals³⁶
• Mar 8, 2024Bought 24,983 shares at $42.25 of Corbus Pharmaceuticals³⁶
• Mar 8, 2024Bought 29,342 shares at $41.23 of Corbus Pharmaceuticals³⁶